The Discounted Cash Flow (DCF) valuation of Castle Biosciences Inc (CSTL) is 9.71 USD. With the latest stock price at 16.75 USD, the upside of Castle Biosciences Inc based on DCF is -42.0%.
Based on the latest price of 16.75 USD and our DCF valuation, Castle Biosciences Inc (CSTL) is a sell. selling CSTL stocks now will result in a potential gain of 42.0%.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 8.0% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 7.06 - 19.53 | 9.71 |
| Upside | -57.9% - 16.6% | -42.0% |